The DOT1L inhibitor pinometostat reduces H3K79 methylation and has modest clinical activity in adult acute leukemiaEytan M. Stein, Martin S. Tallman, Mojca Jongen-Lavrenic et al.|Blood|2018Cited by 457
BCL-2 family proteins as 5-Azacytidine-sensitizing targets and determinants of response in myeloid malignanciesJames M. Bogenberger, Raoul Tibes|Leukemia|2014Cited by 196
The DOT1L Inhibitor EPZ-5676: Safety and Activity in Relapsed/Refractory Patients with MLL-Rearranged LeukemiaEytan M. Stein, Martin S. Tallman, Guillermo Garcia‐Manero et al.|Blood|2014Cited by 44